Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Choose NJ’s RFP Watch

Choose New Jersey’s RFP Watch provides up-to-date information on business opportunities throughout the Garden State at a cost that is affordable for all companies – with a place of business in New Jersey – large and small.

To learn more click here

Event: NJ Rare Disease Alliance to Commemorate Rare Disease Day 2016 on February 29 in Trenton

Rare Disease DayTrenton, NJ, February 27, 2016 ― The New Jersey Rare Disease Alliance (NJRDA) — dedicated to improving the lives of the more than 800,000 rare disease patients in New Jersey — is hosting an event to observe global Rare Disease Day on Monday, February 29 starting at 10:00 a.m. at the New Jersey Business and Industry Association (NJBIA), 10 West Lafayette Street, Trenton.

Sponsored in conjunction with BioNJ, the HealthCare Institute of New Jersey (HINJ) and the National Organization for Rare Diseases (NORD), training will be provided on how to more effectively build relationships with legislators and other policymakers on behalf of rare disease patients.

Following a NORD-sponsored breakfast at 10:00 a.m. there will be an hour of training from 10:30-11:30 a.m. by state legislative experts from HINJ and BioNJ.  Senator Diane Allen (Burlington) will present a ceremonial resolution commemorating Rare Disease Day 2016 in New Jersey.

The session will conclude with an original song performed by Janna Pelle, a talented young songwriter and performer who was inspired by her father’s courageous battle with MDS, a rare bone marrow disorder.

The day’s activities will continue with patients and advocates meeting with legislators at the State House.

Commenting on the February 29 event in Trenton, NJRDA Co-founder Julie Raskin said, “While there has been great progress in the rare disease community, there is still much to be done.”

“We are supporting this year’s global Rare Disease Day theme—‘Join Us in Making the Voices of Rare Disease Heard’—by helping to build a bridge between patients and policymakers,” Raskin added.  “We are looking forward to patients and their advocates joining us for this vital event.”

To attend Rare Disease Day 2016 in Trenton, please send an email to info@njrarediseasealliance.org with the names of the people in your party attending, and any questions you may have.  Together we are stronger.

About The New Jersey Rare Disease Alliance

The New Jersey Rare Disease Alliance (NJRDA) is dedicated to improving the lives of the 800,000 rare disease patients in NJ.  Inclusive of individuals and organizations across the rare disease continuum, the group’s mission is to bring recognition to the issues rare disease patients face and to work together towards better treatment options and improved access to care.  Patients, supporters, advocates, legislators, biopharmaceutical and life science industry executives, healthcare professionals, academia, and individuals committed to making a difference in patients’ lives are all invited to join us.

For more information about NJRDA, please visit www.njrarediseasealliance.org.

About BioNJ

BioNJ is a powerful network of 400 Members representing research-based life sciences companies and other contributors to a vibrant ecosystem where Science is Supported, Companies are Created, Drugs are Developed and Patients are Paramount.  Because Patients Can’t Wait, we are dedicated to propelling this rich, innovation hub forward in New Jersey and beyond to help stimulate the discovery, development and commercialization of therapies and cures that save and improve lives and lessen the burden of illness and disease to society. As the industry’s voice in New Jersey, we fulfill our mission to help companies help patients by driving capital formation and fostering entrepreneurship, advocating for public policies that advance medical innovation, providing access to talent and education, and offering a cost-saving array of critical commercial resources.

For more information about BioNJ, please visit www.BioNJ.org.

About the HealthCare Institute of New Jersey (HINJ)

Founded in 1997, the HealthCare Institute of New Jersey (HINJ) serves as the voice for the state’s life sciences industry. HINJ seeks to expand patient access to the most innovative biopharmaceuticals and medical devices and promote awareness of the industry’s impact on New Jersey’s quality of life and economic well-being.

For more information, visit www.hinj.org.

About NORD

The National Organization for Rare Disorders (NORD), a 501(c)(3) organization, is a unique federation of voluntary health organizations dedicated to helping people with rare “orphan” diseases and assisting the organizations that serve them. NORD is committed to the identification, treatment, and cure of rare disorders through programs of education, advocacy, research, and service.

For more information on NORD visit www.rarediseases.org.